Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2009

Main Data: 31/12 Year 2009
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 505.77
– gross industrial income 217.47
– total operating cost 146.33
– operating profit 71.14
– net financial expenses 10.09
– group profit 36.86

 

Consolidated balance sheet Millions/Euro
– working capital 98.93
– non-current assets 161.41
– provision for severance indemnities and other provisions – 16.71
– net debt – 113.43
– equity pertaining to the group and minority interests 130.20

 

Other information Millions/Euro
– depreciation, amortization and impairment 15.21
– R & D costs 25.95

 

  Euro
Dividend per share 0.90

 

  No.
Employees 3,135

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2009
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 237.4
– gross industrial income 103.3
– total operating cost 73.7
– operating profit 29.6
– net financial expenses 6.9
– gruop profit 13.9

 

Consolidated balance sheet Millions/Euro
– working capital 113.6
– non-current assets 187.1
– provision for severance indemnities and other provisions – 24.0
– net debt – 168.7
– equity pertaining to the group and minority interests 108.0

 

Other information Millions/Euro
– depreciation, amortization and impairment 7.2
– R & D costs 14.7

 

  No.
Employees 3,126

 

  Euro
Share capital 17,732,000

 

Net Sales by Sector: Year 2009
  Millions/Euro  
tea, herbs & coffee 93.79 18.5%
pharmaceuticals packaging 292.91 58.0%
pharmaceuticals processing 119.07 23.5%
Total 505.77 100.0%

 

Net Sales by Country: Year 2009
  Millions/Euro  
E.U. (excluding Italy) 193.79 38.3%
Other European countries 36.28 7.2%
North America 76.40 15.1%
Asia & Middle East 118.24 23.4%
Other countries 44.12 8.7%
Total exports 468.83 92.7%
Italy 36.94 7.3%
Total 505.77 100.0%